Copper peptides have long occupied an intriguing corner of biochemical research, and GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is the most extensively studied member of this class. Discovered in human plasma in the early 1970s by Loren Pickart, GHK-Cu has since been the subject of hundreds of published studies examining its roles in wound healing models, collagen synthesis, antioxidant activity, and gene expression regulation.
This guide provides UK researchers with a comprehensive overview of GHK-Cu's biochemistry, the key findings from the published literature, practical storage and handling considerations, and guidance on sourcing research-grade material in the United Kingdom.
The story of GHK-Cu begins with Loren Pickart's doctoral research at the University of California, San Francisco in the early 1970s. Pickart observed that aged human serum caused liver cells to synthesise proteins at a rate more characteristic of young cells, and through systematic fractionation, he isolated the tripeptide responsible: glycyl-L-histidyl-L-lysine (GHK).
Pickart subsequently demonstrated that GHK has a high affinity for copper(II) ions, forming the GHK-Cu complex at physiological pH. This copper complex, he proposed, was responsible for the biological activity observed. His early publications in the 1970s and 1980s laid the groundwork for decades of subsequent research into the compound's wound healing and tissue-regenerative properties in vitro.
GHK's plasma concentration follows a notable age-related decline — estimated at approximately 200 ng/mL in young adults, falling to around 80 ng/mL by the age of 60 — which has prompted research interest in whether exogenous GHK-Cu supplementation in research models can recapitulate the biological environment of younger tissue.
GHK-Cu consists of the tripeptide Gly-His-Lys chelated to a single copper(II) ion. The histidine imidazole ring and the N-terminal amino group are the primary copper-coordinating sites, forming a stable square planar complex. The molecular weight of the copper complex is approximately 340 Da, making it a notably small and membrane-permeable compound relative to larger peptide research compounds.
The copper coordination chemistry is significant: GHK-Cu operates within a redox-active copper(II)/copper(I) cycle that researchers believe underlies some of its antioxidant and enzyme-modulating properties. The peptide acts as a carrier and donor of bioavailable copper, which is a cofactor for numerous enzymes including lysyl oxidase, superoxide dismutase (SOD), and ceruloplasmin.
The most extensively documented area of GHK-Cu research concerns its effects on collagen production in cell culture models. Multiple in vitro studies have demonstrated that GHK-Cu treatment of fibroblast cultures stimulates type I and type III collagen synthesis, with some studies reporting increases in collagen production of 50–200% over untreated controls depending on concentration and cell type.
Beyond collagen, GHK-Cu has been shown in cell culture models to modulate:
The MMP data is particularly nuanced: GHK-Cu appears to both stimulate certain MMPs (facilitating remodelling of damaged matrix) and increase levels of their inhibitors (TIMPs), suggesting a regulatory rather than simply stimulatory role in extracellular matrix homeostasis.
GHK-Cu has been studied for its antioxidant properties through several mechanisms. As a copper carrier, it facilitates the delivery of copper to Cu/Zn-superoxide dismutase (SOD1), an enzyme central to cellular defence against oxidative stress. Studies in cell culture have reported reductions in reactive oxygen species (ROS) following GHK-Cu treatment.
Additionally, GHK-Cu has been shown in some in vitro models to chelate free iron, reducing iron-catalysed hydroxyl radical generation via the Fenton reaction. This iron-chelating capacity may contribute to its cytoprotective effects in oxidative stress models.
Perhaps the most surprising aspect of GHK-Cu research is the breadth of its reported effects on gene expression. A landmark gene microarray study by Pickart and colleagues, published in 2012, reported that GHK-Cu modulated the expression of over 4,000 human genes in culture. The pathways most significantly affected included:
These findings have been interpreted as consistent with GHK-Cu acting as a broad biological signal for tissue restoration and repair, though researchers note that microarray data requires independent validation for individual gene targets.
GHK-Cu has been incorporated into in vivo wound healing studies in rodent models since the 1980s. Studies have variously reported accelerated wound closure, increased tensile strength of healed tissue, and improved re-epithelialisation in GHK-Cu treated animals compared to controls. Some studies have incorporated GHK-Cu into collagen matrices or hydrogel delivery systems to examine its effects on chronic wound models.
Several published studies have examined GHK-Cu's effects on inflammatory signalling in cell culture models. Reported findings include reductions in TNF-α and IL-6 production in stimulated macrophage cultures, as well as inhibition of NF-κB activation in some experimental conditions. These findings have positioned GHK-Cu as a compound of interest in inflammation research, though human clinical data is limited and the compound remains a research-only material in the UK.
GHK-Cu is frequently compared with related copper-binding peptides such as AHK-Cu (alanyl-histidyl-lysine copper) and GHK-Cu analogues. GHK-Cu remains the most well-studied, with the deepest published literature base. AHK-Cu is considered by some researchers to have a slightly different tissue distribution profile due to the alanine substitution, though comparative data is limited.
It is also distinct from standalone copper sulphate supplementation — the peptide carrier is believed to be essential for directing copper delivery to specific enzymatic targets, rather than simply increasing bulk copper availability.
Research-grade GHK-Cu is typically supplied as a lyophilised powder. In this form, it is stable at -20°C for up to 24 months when stored in a sealed, desiccated container away from light. Refrigerator storage (2–8°C) is acceptable for shorter periods (up to 6 months).
GHK-Cu is readily soluble in aqueous buffers, sterile water, or bacteriostatic water. The copper complex imparts a characteristic blue-green colour to solutions at higher concentrations, which can be used as a visual quality check. Reconstituted solutions should be stored at 2–8°C and used within 4 weeks.
Copper chelation stability is pH-dependent. GHK-Cu is most stable in the pH range of 5.5–7.5. Researchers should avoid strongly acidic or alkaline reconstitution buffers, as these can disrupt the copper-peptide coordination complex.
When using GHK-Cu in cell culture models, researchers should be aware that the copper content can interact with standard culture media formulations, some of which already contain trace copper. High-quality cell culture controls and appropriate copper-depleted media may be required for accurate quantitative studies.
Research-grade GHK-Cu is available from specialist peptide suppliers in the United Kingdom. When evaluating suppliers, researchers should prioritise:
Monumental Peptides supplies GHK-Cu as a research-grade lyophilised powder for laboratory and in vitro research use. Certificate of Analysis documentation is available upon request for all batch numbers.
GHK-Cu is a copper-binding tripeptide (glycyl-L-histidyl-L-lysine copper complex) first isolated by Loren Pickart in the 1970s. In research, it is studied for its effects on collagen synthesis in fibroblast cultures, antioxidant activity, gene expression modulation, and wound healing models. All use is strictly for in vitro and laboratory research only.
Unlike inorganic copper salts, GHK-Cu uses the tripeptide carrier to deliver copper to specific enzymatic targets including SOD1 and lysyl oxidase. The peptide component also independently modulates gene expression and extracellular matrix signalling, making it functionally distinct from simple copper supplementation in research models.
Lyophilised GHK-Cu powder should be stored at -20°C in a sealed, desiccated container protected from light for optimal long-term stability (up to 24 months). Refrigerator storage (2–8°C) is suitable for shorter periods. Once reconstituted in aqueous buffer or bacteriostatic water, store at 2–8°C and use within 4 weeks. Avoid strongly acidic or alkaline pH conditions.
Research-grade GHK-Cu should have HPLC purity of ≥98% for the peptide component, with mass spectrometry confirmation of both the correct peptide molecular weight and the copper complex. Always request a batch-specific Certificate of Analysis before use in any research protocol.
Yes. Monumental Peptides supplies research-grade GHK-Cu to UK-based researchers as a lyophilised powder with full CoA documentation. It is available for in vitro and laboratory research use only. Visit our GHK-Cu product page for current pricing and availability.